Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FOLFOX-Based TAIC for Locally Advanced Gastric Cancer and GEJA
NCT07655024Phase 2Recruiting
- Sponsor
- Guang'anmen Hospital
- Start
- Nov 2025
- Primary completion
- Jan 2028
- Countries
- 1
01
Overview
A Phase 2 trial of fluorouracil, folinic acid, oxaliplatin in gastric cancer (GC), gastroesophageal junction adenocarcinoma, sponsored by Guang'anmen Hospital. Started Nov 2025; status: recruiting.
02
Drugs
fluorouracilfolinic acidoxaliplatin
03
Conditions
gastric cancer (GC)gastroesophageal junction adenocarcinoma
Beyond the preview
Go deeper on NCT07655024.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07655024.